The incidence and mortality of breast cancer are as high as 24.2% and 15%, respectively, ranking first in female malignant tumors. Although the main treatments for breast cancer include surgery, radiotherapy and chemotherapy, side effects and drug resistance are the main problems...
A single dose of carbon nanotubes enhances breast cancer metastasis in mouse models. Iseult Lynch Research Highlight|05 June 2019 Escorted delivery Chiara Pastore News & Views|25 March 2019 Winning the war with iron An FDA-approved iron oxide nanoparticle used for the treatment of anaemia can be...
Expert opinion The conjugation of protein and peptides can improve tumor homing of nanoparticles, increase cellular penetration and attack specific drivers and vulnerabilities of the breast cancer cell to promote tumor cytotoxicity while reducing secondary effects in healthy tissues. Examples are the use ...
Nanotechnology for breast cancer therapy Breast cancer is the field of medicine with the greatest presence of nanotechnological therapeutic agents in the clinic. A pegylated form of liposomally en... T Tanaka,P Decuzzi,M Cristofanilli,... - 《Biomedical Microdevices》 被引量: 203发表: 2009年...
breast cancer cells in animal models, increasing the extent of existing metastasis and promoting the appearance of new metastatic sites. Our results add to the understanding of the behaviour of nanoparticles in complex biological systems. The potential for NanoEL needs to be taken into consideration ...
Whilst nanotechnology is still mostly in the research stage, several applications are ready for translation from the bench to the bedside, in particular in the field of breast cancer. This is exciting new area of research where science fiction may become a reality. 展开 ...
Horizons of nanotechnology applications in female specific cancersFemale specific cancersBreast cancerOvarian cancerCervical cancerNanotechnologyFemale-specific cancers are the most common cancers in women worldwide. Early detection methods remain unavailable for most of these cancers, signifying that most of ...
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nature Cell Biol. 12, 247–256 (2010). Article CAS PubMed Google Scholar Ma, L,. Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. ...
Treatment for metastatic breast cancer, sarcoma in AIDS patients, ovarian and lung cancer is already on market or under final phases of many clinical trials, showing remarkable results. As nanotechnology is perfected, side effects due to normal cell damage will decrease, leading to better results ...
(2016) improved the Dox delivery through ZnONPs by increasing cell uptake and decreasing cell efflux in human breast cancer cells (MCF-7 cells). Results revealed the dual roles of ZnONPs by overcoming drug resistance and probing the intracellular drug release. In an attempt to enhance anticancer...